news
RTOG 0233 Study Results
Study Results Show Dose-Intensified Temozolomide Chemotherapy in the Adjuvant Setting Does Not Improve Survival in Patients with GBM
Research Demonstrates the Potential of PET Imaging for Predicting Patient Prognosis
RTOG Patient Enrollment Continues during Government Shutdown
Men with Intermediate-Risk Prostate Cancer Have Excellent Outcomes with Short Course Hormonal Therapy
Study Results Show Dose-Intensified Temozolomide Chemotherapy in the Adjuvant Setting Does Not Improve Survival in Patients with GBM
Research Demonstrates the Potential of PET Imaging for Predicting Patient Prognosis
RTOG Patient Enrollment Continues during Government Shutdown
Men with Intermediate-Risk Prostate Cancer Have Excellent Outcomes with Short Course Hormonal Therapy
.png)
No hay comentarios:
Publicar un comentario